APPROVED: Genentech/Roche Gazyva 1st breakthrough-designated drug to enter US market

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Cardiovascular

More from Therapy Areas